• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危重症原发性 2009 年甲型 H1N1 流感患者体内血小板的激活。

In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1).

机构信息

Division of General Internal Medicine, University of Utah School of Medicine, Salt Lake City; Department of Internal Medicine, and the Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City.

Department of Internal Medicine, and the Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City.

出版信息

Chest. 2012 Jun;141(6):1490-1495. doi: 10.1378/chest.11-2860. Epub 2012 Mar 1.

DOI:10.1378/chest.11-2860
PMID:22383669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3367488/
Abstract

BACKGROUND

Changes in platelet reactivity during 2009 influenza A(H1N1) (A[H1N1]) have not been characterized.

METHODS

We prospectively examined platelet activation and cytokine responses in patients with A(H1N1) (n = 20), matched patients with bacterial pneumonia (n = 15), and nonhospitalized, healthy control subjects (n = 10).

RESULTS

Platelet-monocyte aggregation was higher in patients with A(H1N1) (21.4% ± 4.7%) compared with patients with pneumonia (10.9% ± 3.7%) and control subjects (8.1% ± 4.5%, P < .05). Similarly, PAC-1 (antibody that binds to the active conformation of integrin α(IIb)β(3)) binding to platelets is increased in patients with A(H1N1) (9.5% ± 4.7%) compared with patients with pneumonia (1.0% ± 0.7%) and healthy subjects (0.61% ± 0.15%, P < .10). PAC-1 binding was twofold higher in patients with A(H1N1) with shock vs those without shock. IL-6 levels were elevated in patients with A(H1N1), indicating systemic inflammation consistent with activation of circulating platelets.

CONCLUSIONS

These findings, derived from a small but documented cohort of patients, demonstrate that platelet activation responses during A(H1N1) are enhanced-exceeding responses in patients with bacterial pneumonia-and provide new evidence that platelets may contribute to inflammatory responses during A(H1N1).

摘要

背景

2009 年甲型 H1N1(A[H1N1])流感期间血小板反应性的变化尚未得到描述。

方法

我们前瞻性地研究了甲型 H1N1(A[H1N1])患者(n=20)、细菌性肺炎患者(n=15)和非住院健康对照者(n=10)的血小板活化和细胞因子反应。

结果

与肺炎患者(10.9%±3.7%)和健康对照者(8.1%±4.5%,P<0.05)相比,A(H1N1)患者的血小板-单核细胞聚集率更高(21.4%±4.7%)。同样,PAC-1(与整合素α(IIb)β(3)的活性构象结合的抗体)与血小板的结合在 A(H1N1)患者中增加(9.5%±4.7%),与肺炎患者(1.0%±0.7%)和健康受试者(0.61%±0.15%)相比,差异有统计学意义(P<0.10)。伴有休克的 A(H1N1)患者与无休克的患者相比,PAC-1 结合增加了两倍。A(H1N1)患者的白细胞介素 6(IL-6)水平升高,表明存在全身性炎症,这与循环血小板的活化一致。

结论

这些发现来自于一个经过充分记录的小患者队列,表明在 A(H1N1)期间血小板活化反应增强——超过了细菌性肺炎患者的反应——并提供了新的证据表明血小板可能有助于 A(H1N1)期间的炎症反应。

相似文献

1
In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1).危重症原发性 2009 年甲型 H1N1 流感患者体内血小板的激活。
Chest. 2012 Jun;141(6):1490-1495. doi: 10.1378/chest.11-2860. Epub 2012 Mar 1.
2
Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.严重甲型流感病毒感染中的高细胞因子血症和磷酸化p38丝裂原活化蛋白激酶的过度激活。
Clin Infect Dis. 2007 Sep 15;45(6):723-31. doi: 10.1086/520981. Epub 2007 Aug 8.
3
Characteristics of acute kidney injury in patients infected with the 2009 influenza A (H1N1) virus.2009 年甲型 H1N1 流感病毒感染患者的急性肾损伤特征。
Clin J Am Soc Nephrol. 2010 Nov;5(11):1916-21. doi: 10.2215/CJN.00840110. Epub 2010 Jul 29.
4
Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection.微小RNA-150的循环水平与甲型H1N1流感感染的较差预后相关。
Exp Mol Pathol. 2015 Oct;99(2):253-61. doi: 10.1016/j.yexmp.2015.07.001. Epub 2015 Jul 3.
5
TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia.转化生长因子-β血液水平可区分甲型H1N1流感病毒败血症与其他形式社区获得性肺炎所致败血症。
Viral Immunol. 2015 Jun;28(5):248-54. doi: 10.1089/vim.2014.0123. Epub 2015 Apr 29.
6
Indication for a role of regulatory T cells for the advent of influenza A (H1N1)-related pneumonia.调节性 T 细胞在甲型 H1N1 流感相关性肺炎发病机制中的作用。
Clin Exp Immunol. 2010 Sep;161(3):576-83. doi: 10.1111/j.1365-2249.2010.04208.x.
7
Comparative study of hematological and radiological feature of severe/critically ill patients with COVID-19, influenza A H7N9, and H1N1 pneumonia.新型冠状病毒肺炎、甲型 H7N9 流感和 H1N1 肺炎重症/危重症患者血液学和影像学特征的比较研究。
J Clin Lab Anal. 2021 Dec;35(12):e24100. doi: 10.1002/jcla.24100. Epub 2021 Nov 11.
8
High mortality in critically ill patients infected with 2009 pandemic influenza A (H1N1) with pneumonia and acute kidney injury.2009年甲型H1N1大流行性流感合并肺炎及急性肾损伤的重症患者死亡率高。
Saudi J Kidney Dis Transpl. 2011 Jan;22(1):83-9.
9
Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection.甲型 H1N1 流感大流行期间危重症患者血清甘露糖结合凝集素水平与重症结局的前瞻性观察性研究。
Lung. 2018 Feb;196(1):65-72. doi: 10.1007/s00408-017-0067-5. Epub 2017 Dec 22.
10
Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.降钙素原水平在 H1N1 流感 A 病毒肺炎的重症监护病房患者中低于社区获得性细菌性肺炎的患者。一项初步研究。
J Crit Care. 2011 Apr;26(2):201-5. doi: 10.1016/j.jcrc.2010.07.009. Epub 2010 Sep 1.

引用本文的文献

1
Differential platelet protein release profiles in community-acquired pneumonia and COVID-19.社区获得性肺炎和新冠肺炎中血小板蛋白释放差异谱
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.00863-2024. eCollection 2025 May.
2
Infective or Non-Infective Endocarditis: A Brief Literature Review Based on a Case Report.感染性或非感染性心内膜炎:基于病例报告的简要文献综述
J Clin Med. 2025 Apr 14;14(8):2675. doi: 10.3390/jcm14082675.
3
Attachment orientation and platelet activity.依恋取向与血小板活性。
Health Psychol. 2025 Sep;44(9):898-908. doi: 10.1037/hea0001501. Epub 2025 Apr 21.
4
Typical Hemolytic Uremic Syndrome Secondary to Influenza A in a Pediatric Patient With Complex Comorbidities: A Rare Encounter.一名患有复杂合并症的儿科患者继发于甲型流感的典型溶血性尿毒症综合征:一次罕见病例。
Cureus. 2024 Jul 30;16(7):e65746. doi: 10.7759/cureus.65746. eCollection 2024 Jul.
5
Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.以 glenzocimab 靶向 GPVI 在 COVID-19 患者中的应用:一项随机临床试验结果。
PLoS One. 2024 Jun 17;19(6):e0302897. doi: 10.1371/journal.pone.0302897. eCollection 2024.
6
Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.奥司他韦和玛巴洛沙韦上市后的安全性分析:基于 FDA 不良事件报告系统的药物警戒研究。
BMC Infect Dis. 2024 May 9;24(1):446. doi: 10.1186/s12879-024-09339-4.
7
The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.补体系统在溶血尿毒综合征感染形式发病机制中的作用。
Biomolecules. 2023 Dec 27;14(1):39. doi: 10.3390/biom14010039.
8
Plasma growth factors maintain constitutive translation in platelets to regulate reactivity and thrombotic potential.血浆生长因子维持血小板中的组成型翻译,以调节反应性和血栓形成潜力。
Blood Adv. 2024 Mar 26;8(6):1550-1566. doi: 10.1182/bloodadvances.2023011734.
9
Performance of Platelet Mass Index as a Marker of Severity for Sepsis and Septic Shock in Children.血小板质量指数作为儿童脓毒症和脓毒性休克严重程度标志物的表现
J Pediatr Intensive Care. 2021 Jun 22;12(3):228-234. doi: 10.1055/s-0041-1731434. eCollection 2023 Sep.
10
Evaluating Effects of AIV Infection Status on Ducks Using a Flow Cytometry-Based Differential Blood Count.使用流式细胞术基于差异血细胞计数评估 AIV 感染状态对鸭的影响。
Microbiol Spectr. 2023 Aug 17;11(4):e0435122. doi: 10.1128/spectrum.04351-22. Epub 2023 Jun 15.

本文引用的文献

1
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.血小板:止血、炎症和免疫连续统中的多功能效应细胞。
Semin Immunopathol. 2012 Jan;34(1):5-30. doi: 10.1007/s00281-011-0286-4. Epub 2011 Aug 6.
2
Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A(H1N1)v severe pneumonia.3例2009甲型H1N1流感重症肺炎患者支气管肺泡灌洗和血清中的细胞因子水平
J Infect Dev Ctries. 2011 Jul 27;5(7):540-3. doi: 10.3855/jidc.1618.
3
Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009.甲型 H1N1 流感大流行的临床和流行病学特征的系统评价。
Influenza Other Respir Viruses. 2011 May;5(3):148-56. doi: 10.1111/j.1750-2659.2011.00199.x. Epub 2011 Mar 15.
4
Pandemic H1N1 influenza infection and vascular thrombosis.大流行性 H1N1 流感感染与血管血栓形成。
Clin Infect Dis. 2011 Jan 15;52(2):e14-7. doi: 10.1093/cid/ciq125.
5
Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice.血小板激活因子受体在甲型流感病毒引起的小鼠肺损伤和死亡中发挥作用。
PLoS Pathog. 2010 Nov 4;6(11):e1001171. doi: 10.1371/journal.ppat.1001171.
6
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.TAK-242 治疗严重脓毒症的随机、双盲、安慰剂对照试验。
Crit Care Med. 2010 Aug;38(8):1685-94. doi: 10.1097/CCM.0b013e3181e7c5c9.
7
Clinical review: primary influenza viral pneumonia.临床综述:原发性流感病毒性肺炎。
Crit Care. 2009;13(6):235. doi: 10.1186/cc8183. Epub 2009 Dec 21.
8
Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection.因新型 2009 流感 A(H1N1)感染而入住犹他州 ICU 的临床发现和人口统计学因素。
Chest. 2010 Apr;137(4):752-8. doi: 10.1378/chest.09-2517. Epub 2009 Nov 20.
9
Platelet functions beyond hemostasis.血小板的止血功能以外的作用。
J Thromb Haemost. 2009 Nov;7(11):1759-66. doi: 10.1111/j.1538-7836.2009.03586.x. Epub 2009 Aug 19.
10
Amicus or adversary: platelets in lung biology, acute injury, and inflammation.友方还是敌方:血小板在肺生物学、急性损伤及炎症中的作用
Am J Respir Cell Mol Biol. 2009 Feb;40(2):123-34. doi: 10.1165/rcmb.2008-0241TR. Epub 2008 Aug 21.